Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2014
11/20/2014US20140343038 1,2,4-triazine-6-carboxamide derivative
11/20/2014US20140343037 Benzene, pyridine, and pyridazine derivatives
11/20/2014US20140343029 Novel Imidazole Amines as Modulators of Kinase Activity
11/20/2014US20140343006 HIV Replication Inhibiting Pyrimidines
11/20/2014US20140341986 Biguanide Compositions and Methods of Treating Metabolic Disorders
11/20/2014US20140341851 Novel benzimidazole derivatives
11/20/2014US20140341850 Haloalkyl heteroaryl benzamide compounds
11/18/2014US8889878 Haloalky-substituted amides as insecticides and acaricides
11/18/2014US8889874 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof
11/18/2014US8889804 Method for preparing polypropylene using transition metal compound containing thiophene-fused cyclopentadienyl ligand
11/18/2014US8889732 Fused heterocyclic compounds and thrombopoietin receptor activators
11/18/2014US8889726 Chemica compounds
11/18/2014US8889716 Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/18/2014US8889709 Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
11/18/2014US8889708 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889664 Phosphatidylinositol 3-kinase inhibitors and methods of their use
11/18/2014US8889581 Catalyst composition for olefin polymerization and preparation method for polyolefin using the same
11/13/2014US20140336381 Fast-dissociating dopamine 2 receptor antagonists
11/13/2014US20140336376 Pharmaceutical composition for treating diabetes
11/13/2014US20140336222 SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
11/13/2014US20140336208 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
11/13/2014US20140336200 Arylosulfonamides for the treatment of cns diseases
11/13/2014US20140336191 Quinolinyloxyphenylsulfonamides
11/13/2014US20140336174 Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease
11/13/2014US20140336168 Nampt inhibitors
11/13/2014US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
11/13/2014US20140334027 Oxime ester photoinitiators
11/11/2014US8884030 Inhibitors of Flaviviridae viruses
11/11/2014US8884028 Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates
11/11/2014US8883962 Zinc-responsive peptides, and methods of use thereof
11/11/2014US8883824 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/11/2014US8883810 Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
11/11/2014US8883798 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof
11/11/2014US8883797 Metalloenzyme inhibitor compounds
11/11/2014US8883793 Tubulin inhibitors and methods of using the same
11/11/2014US8883792 Substituted isoquinoline derivative
11/11/2014US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
11/11/2014US8883776 Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine H3 receptor
11/11/2014US8883432 Coelenterazine analogues and coelenteramide analogues
11/06/2014US20140330007 2,4-pyrimidinediamine compounds and their uses
11/06/2014US20140329871 Small molecule anti-fibrotic compounds and uses thereof
11/06/2014US20140329858 Cyclic Urea Derivatives As Androgen Receptor Antagonists
11/06/2014US20140329857 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/06/2014US20140329821 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
11/06/2014US20140329805 Dual small molecule inhibitors of cancer and angiogenesis
11/06/2014US20140329802 Tetrahydrobenzothiophene compound
11/06/2014US20140329798 Substituted cyclopropyl compounds useful as gpr119 agonists
11/06/2014US20140329796 Heterocyclic amide derivative and pharmaceutical product containing same
11/04/2014US8877944 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP inhibitors
11/04/2014US8877924 Benzyl substituted triazine derivatives and their therapeutical applications
11/04/2014US8877923 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitors
11/04/2014US8877801 Compounds and compositions as selective estrogen receptor degraders
11/04/2014US8877780 5-substituted isoindoline compounds
11/04/2014US8877757 Pyrazine derivatives and use as PI3K inhibitors
11/04/2014US8877707 Inhibitors of HCV NS5A
11/04/2014US8877315 Indolium compound and optical recording material containing the same
10/2014
10/30/2014US20140323736 Use of aryl and hetaryl carboxamides as endoparasiticides
10/30/2014US20140323518 Novel estrogen receptor ligands
10/30/2014US20140323510 Substituted arylcyclopentenes as therapeutic agents
10/30/2014US20140323502 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
10/30/2014US20140323482 Substituted piperidines as hdm2 inhibitors
10/30/2014US20140323448 sGC STIMULATORS
10/30/2014US20140323447 Heteroaromatic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
10/30/2014US20140322247 Cell proliferation inhibitors and conjugates thereof
10/28/2014US8871930 Preparation method of alpha-imatinib mesylate
10/28/2014US8871929 Fused-imidazoyl compounds useful as antimicrobial agents
10/28/2014US8871796 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
10/28/2014US8871785 Antiviral phosphonate analogs
10/28/2014US8871777 Phenylpyrimidone compounds, the pharmaceutical compositions, preparation methods and uses thereof
10/28/2014US8871757 6-and 7-amino isoquinoline compounds and methods for making and using the same
10/28/2014US8871756 Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
10/28/2014US8871753 Macrocyclic compounds and their use as kinase inhibitors
10/28/2014US8871726 C-aryl glucoside derivative, preparation method therefor, and use thereof
10/23/2014US20140316137 Coelenterazine analogues and coelenteramide analogues
10/23/2014US20140315945 Substituted Benzene Compounds
10/23/2014US20140315913 Substituted pyridine and pyrazine compounds as pde4 inhibitors
10/23/2014US20140315899 Sulfonamides as trpm8 modulators
10/23/2014US20140315887 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/23/2014US20140315884 Ampk-activating heterocyclic compounds and methods for using the same
10/23/2014US20140315857 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/23/2014US20140315845 Hsp90 inhibitors with modified toxicity
10/21/2014US8865912 Benzimidazole derivatives as PI3 kinase inhibitors
10/21/2014US8865754 Compounds for the treatment of neurodegenerative diseases
10/21/2014US8865723 Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865714 Piperazine compound capable of inhibiting prostaglandin D synthase
10/21/2014US8865704 Wnt pathway antagonists
10/21/2014US8865703 Pyridyltriazoles
10/21/2014US8865682 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
10/21/2014US8865623 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds
10/16/2014US20140309266 Antimicrobial/adjuvant compounds and methods
10/16/2014US20140309259 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309248 Substituted indolyl alkyl amino derivatives as inhibitors of histone deacetylase
10/16/2014US20140309240 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309210 Indazole compounds, compositions and methods of use thereof
10/16/2014US20140309209 Pyrazine Kinase Inhibitors
10/16/2014US20140309187 Solid forms of an antiviral compound
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/14/2014US8859814 Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 523